Metformin Safety Warnings and Diabetes Drug Prescribing Patterns for Older Nursing Home Residents.

The study looked only at which diabetes drug was started. It did not measure whether residents had hypoglycemia, lactic acidosis, or other harms. Diabetes duration, blood sugar control, and patient preferences were not available, and these can affect drug choice. Some residents may have used glucose-lowering medications before the six-month lookback period, so past treatment history or prior adverse effects could have influenced the choice. The sample was Medicare Fee-For-Service long-stay nursing home residents without Medicare Advantage, so it may not apply to other nursing home residents or current prescribing patterns. DPP-4 inhibitors and thiazolidinediones were alternatives in the study period but were used less often than sulfonylureas, and current choices may differ.

Do not read the association between kidney disease, heart failure, dialysis, or advanced age and sulfonylurea initiation as proof that this choice harmed residents. The study measured which drug was prescribed, not hypoglycemia, lactic acidosis, or other outcomes.